Hartford Funds Management »

Vertex Pharmaceuticals Incorporated shares owned by Hartford Funds Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Hartford Funds Management from 13F filings

Historical chart of Hartford Funds Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Hartford Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Hartford Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $362k 890 406.71
2023-09-30 $287k 826 347.91
2023-06-30 $272k 773 352.00
2023-03-31 $210k 666 315.37

More positions owned by Hartford Funds Management

Hartford Fds Exchange Traded Total Rtrn Etf (HTRB)
Hartford Fds Exchange Traded Core Bd Etf (HCRB)
Lattice Strategies Tr Hartford Us Eqty (ROUS)
Lattice Strategies Tr Hartford Mlt Etf (RODM)
Hartford Fds Exchange Traded Large Cap Grwt (HFGO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
Amazon (AMZN)
American Express Company (AXP)
Broadcom (AVGO)
Duke Energy Corp Com New (DUK)

View all positions for Hartford Funds Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated